News Focus
News Focus
Followers 55
Posts 2312
Boards Moderated 0
Alias Born 06/28/2012

Re: MinnieM post# 54212

Wednesday, 02/12/2014 3:04:34 PM

Wednesday, February 12, 2014 3:04:34 PM

Post# of 405214
It certainly is. And frankly, I think sometimes the man doesn't get enough credit. Now, that's not to say there aren't questions that need to be answered or steps to be taken to advance the company from a business development standpoint. I believe those answers and those steps will happen at the appropriate time.

The bottom line here is, within the next month or so, we should have all 3 of our major compounds in FDA approved human clinical trials. On their way to delivering tangible results that will have positive impact on the business to varying degrees.

Considering when Leo took over the company as CEO, it was on the verge of collapse, I give him a lot of credit for getting the company to where it is today.

Even if you are a skeptic of Leo/Dr. Menon, I think it is fair to at least concede that getting all 3 compounds into human clinical trials and out of the hands of mgmt. is at least a positive step forward toward bringing true value to CTIX.

Meanwhile, Kevetrin cohort 7 presumably marches on at 165mg/m2. I wonder what those results look like?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y